Cargando…
In Vitro Selection of Probiotics, Prebiotics, and Antioxidants to Develop an Innovative Synbiotic (NatuREN G) and Testing Its Effect in Reducing Uremic Toxins in Fecal Batches from CKD Patients
We aimed to develop an innovative synbiotic formulation for use in reducing dysbiosis, uremic toxins (e.g., p-cresol and indoxyl sulfate), and, consequently, the pathognomonic features of patients with chronic kidney disease (CKD). Twenty-five probiotic strains, belonging to lactobacilli and Bifidob...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235484/ https://www.ncbi.nlm.nih.gov/pubmed/34204263 http://dx.doi.org/10.3390/microorganisms9061316 |
_version_ | 1783714329376325632 |
---|---|
author | Vacca, Mirco Celano, Giuseppe Lenucci, Marcello Salvatore Fontana, Sergio la Forgia, Flavia Maria Minervini, Fabio Scarano, Aurelia Santino, Angelo Dalfino, Giuseppe Gesualdo, Loreto De Angelis, Maria |
author_facet | Vacca, Mirco Celano, Giuseppe Lenucci, Marcello Salvatore Fontana, Sergio la Forgia, Flavia Maria Minervini, Fabio Scarano, Aurelia Santino, Angelo Dalfino, Giuseppe Gesualdo, Loreto De Angelis, Maria |
author_sort | Vacca, Mirco |
collection | PubMed |
description | We aimed to develop an innovative synbiotic formulation for use in reducing dysbiosis, uremic toxins (e.g., p-cresol and indoxyl sulfate), and, consequently, the pathognomonic features of patients with chronic kidney disease (CKD). Twenty-five probiotic strains, belonging to lactobacilli and Bifidobacterium, were tested for their ability to grow in co-culture with different vegetable (pomegranate, tomato, and grapes) sources of antioxidants and prebiotics (inulin, fructo-oligosaccharides, and β-glucans). Probiotics were selected based on the acidification rates and viable cell counts. Inulin and fructo-oligosaccharides reported the best prebiotic activity, while a pomegranate seed extract was initially chosen as antioxidant source. The investigation was also conducted in fecal batches from healthy and CKD subjects, on which metabolomic analyses (profiling volatile organic compounds and total free amino acids) were conducted. Two out of twenty-five probiotics were finally selected. After the stability tests, the selective innovative synbiotic formulation (named NatuREN G) comprised Bifidobacterium animalis BLC1, Lacticaseibacillus casei LC4P1, fructo-oligosaccharides, inulin, quercetin, resveratrol, and proanthocyanidins. Finally, NatuREN G was evaluated on fecal batches collected from CKD in which modified the viable cell densities of some cultivable bacterial patterns, increased the concentration of acetic acid and decane, while reduced the concentration of nonanoic acid, dimethyl trisulfide, and indoxyl sulfate. |
format | Online Article Text |
id | pubmed-8235484 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-82354842021-06-27 In Vitro Selection of Probiotics, Prebiotics, and Antioxidants to Develop an Innovative Synbiotic (NatuREN G) and Testing Its Effect in Reducing Uremic Toxins in Fecal Batches from CKD Patients Vacca, Mirco Celano, Giuseppe Lenucci, Marcello Salvatore Fontana, Sergio la Forgia, Flavia Maria Minervini, Fabio Scarano, Aurelia Santino, Angelo Dalfino, Giuseppe Gesualdo, Loreto De Angelis, Maria Microorganisms Article We aimed to develop an innovative synbiotic formulation for use in reducing dysbiosis, uremic toxins (e.g., p-cresol and indoxyl sulfate), and, consequently, the pathognomonic features of patients with chronic kidney disease (CKD). Twenty-five probiotic strains, belonging to lactobacilli and Bifidobacterium, were tested for their ability to grow in co-culture with different vegetable (pomegranate, tomato, and grapes) sources of antioxidants and prebiotics (inulin, fructo-oligosaccharides, and β-glucans). Probiotics were selected based on the acidification rates and viable cell counts. Inulin and fructo-oligosaccharides reported the best prebiotic activity, while a pomegranate seed extract was initially chosen as antioxidant source. The investigation was also conducted in fecal batches from healthy and CKD subjects, on which metabolomic analyses (profiling volatile organic compounds and total free amino acids) were conducted. Two out of twenty-five probiotics were finally selected. After the stability tests, the selective innovative synbiotic formulation (named NatuREN G) comprised Bifidobacterium animalis BLC1, Lacticaseibacillus casei LC4P1, fructo-oligosaccharides, inulin, quercetin, resveratrol, and proanthocyanidins. Finally, NatuREN G was evaluated on fecal batches collected from CKD in which modified the viable cell densities of some cultivable bacterial patterns, increased the concentration of acetic acid and decane, while reduced the concentration of nonanoic acid, dimethyl trisulfide, and indoxyl sulfate. MDPI 2021-06-17 /pmc/articles/PMC8235484/ /pubmed/34204263 http://dx.doi.org/10.3390/microorganisms9061316 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Vacca, Mirco Celano, Giuseppe Lenucci, Marcello Salvatore Fontana, Sergio la Forgia, Flavia Maria Minervini, Fabio Scarano, Aurelia Santino, Angelo Dalfino, Giuseppe Gesualdo, Loreto De Angelis, Maria In Vitro Selection of Probiotics, Prebiotics, and Antioxidants to Develop an Innovative Synbiotic (NatuREN G) and Testing Its Effect in Reducing Uremic Toxins in Fecal Batches from CKD Patients |
title | In Vitro Selection of Probiotics, Prebiotics, and Antioxidants to Develop an Innovative Synbiotic (NatuREN G) and Testing Its Effect in Reducing Uremic Toxins in Fecal Batches from CKD Patients |
title_full | In Vitro Selection of Probiotics, Prebiotics, and Antioxidants to Develop an Innovative Synbiotic (NatuREN G) and Testing Its Effect in Reducing Uremic Toxins in Fecal Batches from CKD Patients |
title_fullStr | In Vitro Selection of Probiotics, Prebiotics, and Antioxidants to Develop an Innovative Synbiotic (NatuREN G) and Testing Its Effect in Reducing Uremic Toxins in Fecal Batches from CKD Patients |
title_full_unstemmed | In Vitro Selection of Probiotics, Prebiotics, and Antioxidants to Develop an Innovative Synbiotic (NatuREN G) and Testing Its Effect in Reducing Uremic Toxins in Fecal Batches from CKD Patients |
title_short | In Vitro Selection of Probiotics, Prebiotics, and Antioxidants to Develop an Innovative Synbiotic (NatuREN G) and Testing Its Effect in Reducing Uremic Toxins in Fecal Batches from CKD Patients |
title_sort | in vitro selection of probiotics, prebiotics, and antioxidants to develop an innovative synbiotic (naturen g) and testing its effect in reducing uremic toxins in fecal batches from ckd patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235484/ https://www.ncbi.nlm.nih.gov/pubmed/34204263 http://dx.doi.org/10.3390/microorganisms9061316 |
work_keys_str_mv | AT vaccamirco invitroselectionofprobioticsprebioticsandantioxidantstodevelopaninnovativesynbioticnaturengandtestingitseffectinreducinguremictoxinsinfecalbatchesfromckdpatients AT celanogiuseppe invitroselectionofprobioticsprebioticsandantioxidantstodevelopaninnovativesynbioticnaturengandtestingitseffectinreducinguremictoxinsinfecalbatchesfromckdpatients AT lenuccimarcellosalvatore invitroselectionofprobioticsprebioticsandantioxidantstodevelopaninnovativesynbioticnaturengandtestingitseffectinreducinguremictoxinsinfecalbatchesfromckdpatients AT fontanasergio invitroselectionofprobioticsprebioticsandantioxidantstodevelopaninnovativesynbioticnaturengandtestingitseffectinreducinguremictoxinsinfecalbatchesfromckdpatients AT laforgiaflaviamaria invitroselectionofprobioticsprebioticsandantioxidantstodevelopaninnovativesynbioticnaturengandtestingitseffectinreducinguremictoxinsinfecalbatchesfromckdpatients AT minervinifabio invitroselectionofprobioticsprebioticsandantioxidantstodevelopaninnovativesynbioticnaturengandtestingitseffectinreducinguremictoxinsinfecalbatchesfromckdpatients AT scaranoaurelia invitroselectionofprobioticsprebioticsandantioxidantstodevelopaninnovativesynbioticnaturengandtestingitseffectinreducinguremictoxinsinfecalbatchesfromckdpatients AT santinoangelo invitroselectionofprobioticsprebioticsandantioxidantstodevelopaninnovativesynbioticnaturengandtestingitseffectinreducinguremictoxinsinfecalbatchesfromckdpatients AT dalfinogiuseppe invitroselectionofprobioticsprebioticsandantioxidantstodevelopaninnovativesynbioticnaturengandtestingitseffectinreducinguremictoxinsinfecalbatchesfromckdpatients AT gesualdoloreto invitroselectionofprobioticsprebioticsandantioxidantstodevelopaninnovativesynbioticnaturengandtestingitseffectinreducinguremictoxinsinfecalbatchesfromckdpatients AT deangelismaria invitroselectionofprobioticsprebioticsandantioxidantstodevelopaninnovativesynbioticnaturengandtestingitseffectinreducinguremictoxinsinfecalbatchesfromckdpatients |